Testing effectiveness (Phase 2)UnknownNCT03595995What this trial is testingTrial to Evaluate the Safety and Efficacy of UB-621Who this might be right forGenital Herpes United BioPharma 80
Not applicableStudy completedNCT00946556What this trial is testingExamining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the CervixWho this might be right forHerpes Simplex Type Two InfectionHIV Infections University of Toronto 30
Not applicableStudy completedNCT01112956What this trial is testingSerologic Assays for the Diagnosis of Herpes Simplex Virus Type 2Who this might be right forGenital Herpes Centers for Disease Control and Prevention 2,500
Testing effectiveness (Phase 2)UnknownNCT04714060What this trial is testingUB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the GenitalsWho this might be right forRecurrent Genital Herpes UBP Greater China (Shanghai) Co., Ltd 44
Early research (Phase 1)Active Not RecruitingNCT05432583What this trial is testingA Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes LesionsWho this might be right forGenital Herpes Simplex Type 2 BioNTech SE 318
Large-scale testing (Phase 3)Study completedNCT00164424What this trial is testingEpisodic Acyclovir Therapy for Genital UlcersWho this might be right forHIV InfectionsUlcerHerpes Simplex Centers for Disease Control and Prevention 613
Early research (Phase 1)Enrolling By InvitationNCT07330440What this trial is testingA Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-VaccinationWho this might be right forGenital Herpes Changchun BCHT Biotechnology Co. 144
Not applicableStudy completedNCT02986802What this trial is testingComparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy OutcomesWho this might be right forHSV-2 InfectionPreTerm BirthPregnancy Complications Kaiser Permanente 89,132
Not applicableStudy completedNCT03090802What this trial is testingMAMAS: Mentoring Adolescent Mothers at SchoolWho this might be right forHuman Immunodeficiency VirusHerpes Simplex Type IIChlamydia+2 more Drexel University 152
Testing effectiveness (Phase 2)Study completedNCT02030301What this trial is testingSafety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsWho this might be right forGenital Herpes Simplex Type 2 Vical 165
Not applicableStudy completedNCT04950712What this trial is testingAn Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.Who this might be right forHerpes Genitalis GlaxoSmithKline 537
Testing effectiveness (Phase 2)Study completedNCT01687595What this trial is testingBiological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital HerpesWho this might be right forHerpes Simplex Type 2 Agenus Inc. 80
Early research (Phase 1)Study completedNCT01453075What this trial is testingEvaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)Who this might be right forChronic Hepatitis C Infection VA Office of Research and Development 31
Not applicableWithdrawnNCT04294030What this trial is testingNOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2Who this might be right forHSV-2 InfectionHerpes Simplex Virus Infection NOWDiagnostics, Inc.
Post-approval studies (Phase 4)Study completedNCT00723229What this trial is testingTrial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 ReactivationWho this might be right forGenital Herpes University of Washington 48
Early research (Phase 1)Study completedNCT00331032What this trial is testingVivaGel™ in Healthy Young WomenWho this might be right forHerpes Simplex II National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT01667341What this trial is testingSafety and Immunogenicity Study of Therapeutic HSV-2 VaccineWho this might be right forGenital Herpes Simplex Type 2 Genocea Biosciences, Inc. 143
Not applicableStudy completedNCT03701802What this trial is testingImmunogenetic Modulators of Mucosal Protection From HIV-1Who this might be right forHIV InfectionsHSV-2 Infection University of Washington 812
Large-scale testing (Phase 3)Study completedNCT00209313What this trial is testingUsage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in CameroonWho this might be right forHIV-1 and HSV-2 CoinfectionHIV Infections Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)UnknownNCT00124878What this trial is testingTrial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the CommunityWho this might be right forHIV InfectionsSexually Transmitted DiseasesPapillomavirus Infections+5 more Wawer, Maria J., M.D. 5,200